Number of the records: 1
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial
- 1.ROB, L., MALLMANN, P., KNAPP, P., MELICHAR, B., KLAT, J., MINÁŘ, L., NOVOTNÝ, Z., BARTŮŇKOVÁ, J., SPÍŠEK, R., PECEN, L., BIN HASSAN, H. I., CIBULA, D. Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial. Journal of Clinical Oncology. 2018, 36(15 S), 5509. ISSN 0732-183X. E-ISSN 1527-7755. Available: https://doi.org/10.1200/JCO.2018.36.15_suppl.5509
Number of the records: 1